Boule Diagnostics AB

Boule Diagnostics has a market price of 3.52 SEK and a market capitalization of 136,692,526.08 SEK, with a price-to-book ratio of 0.28 and a price-to-tangible-book ratio of 0.28, indicating a significant discount to its book value. The company's enterprise value to EBITDA ratio is 203.78, and its enterprise value to revenue is 2.08, suggesting a low valuation relative to its revenue but a high multiple on earnings. The company's liquidity position is characterized by a current ratio of 1.23 and a cash and equivalents balance of 34.7 million SEK, which is insufficient to cover its long-term debt of 183.3 million SEK.

Profitability metrics show a return on equity of -0.32% and a return on assets of -0.20%, indicating that the company is not generating returns for its shareholders or assets. The operating margin is 1.02%, and the net margin is -0.12%, reflecting a narrow operating profit and a net loss. These figures are below the industry median for profitability, suggesting that Boule Diagnostics is underperforming its peers in terms of generating returns.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases its exposure to market-specific risks. The capital expenditure of -3.7 million SEK indicates that the company is not investing in new assets, which may limit its growth potential. The company's free cash flow of 1.1 million SEK is minimal, suggesting that it has limited capacity to fund operations or growth initiatives.

Looking ahead, the company's revenue is expected to remain flat, with no significant growth anticipated in the next fiscal year. The company's net loss of 1.6 million SEK and a negative return on equity suggest that it is not currently generating value for shareholders. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the company's net cash position is negative after subtracting total debt, which could impact its financial flexibility.

Recent events, including the company's financial performance and analyst estimates, suggest that the company is facing challenges in generating consistent earnings and maintaining a positive return on investment. The company's mean recommendation from analysts is a "Hold," with no strong buy or buy ratings, indicating a cautious outlook from the investment community. The last actual EPS was -0.10 SEK, significantly below the mean EPS estimate of 0.82 SEK, highlighting the company's earnings shortfall.

Operating income surged 106% year-over-year to SEK 20.8 million, signaling a strong operational recovery from the prior fiscal year's losses.

Free cash flow improved by 105.4% to SEK 15.3 million, demonstrating a significant restoration of cash generation capabilities.

Return on equity of -0.3% is significantly better than the cohort median of -4.7%, suggesting relatively efficient use of shareholder capital.

Long-term debt increased to SEK 223.8 million, representing a rising leverage burden amidst declining revenue trends.

The company faces high credit risk, posing potential challenges for future financing and operational stability.

Debt-to-equity ratio of 0.37 is significantly higher than the cohort median of 0.06, indicating elevated financial leverage.

Cash conversion of -16.44% falls in the bottom quartile of the cohort, highlighting poor efficiency in converting earnings to cash.

Revenue kr 489.7M, +333,8% YoY.

• ▍Revenue kr 489.7M, +333,8% YoY

Revenue kr 120.3M, −16,0% YoY; Operating income +112,2% YoY.

• ▍Revenue kr 120.3M, −16,0% YoY
• ▍Operating income +112,2% YoY
• ▍Net income +102,2% YoY
• ▍Free cash flow +110,2% YoY
• ▍Net margin 1.4%

Revenue kr 127.2M, −2,5% YoY; Operating income +106,0% YoY.

• ▍Revenue kr 127.2M, −2,5% YoY
• ▍Operating income +106,0% YoY
• ▍Net income +104,8% YoY
• ▍Free cash flow +106,4% YoY
• ▍Net margin 8.6%

Revenue kr 129.3M, −5,6% YoY; Operating income −7,1% YoY.

• ▍Revenue kr 129.3M, −5,6% YoY
• ▍Operating income −7,1% YoY
• ▍Net income −256,2% YoY
• ▍Free cash flow −90,9% YoY
• ▍Net margin -4.4%

Revenue kr 112.9M; Operating income -kr 6.4M.

• ▍Revenue kr 112.9M
• ▍Operating income -kr 6.4M
• ▍Net margin -9.1%

Revenue kr 143.3M; Operating income -kr 87.6M.

• ▍Revenue kr 143.3M
• ▍Operating income -kr 87.6M
• ▍Net margin -52.8%

Revenue kr 130.4M; Operating income -kr 278.9M.

• ▍Revenue kr 130.4M
• ▍Operating income -kr 278.9M
• ▍Net margin -175.8%

Revenue kr 137.0M; Operating income kr 1.4M.

• ▍Revenue kr 137.0M
• ▍Operating income kr 1.4M
• ▍Net margin -1.2%

Revenue kr 489.7M, −12,3% YoY; Operating income +106,0% YoY.

• ▍Revenue kr 489.7M, −12,3% YoY
• ▍Operating income +106,0% YoY
• ▍Net income +98,7% YoY
• ▍Free cash flow +105,5% YoY
• ▍Net margin -0.8%

Revenue kr 558.5M, −2,2% YoY; Operating income −990,5% YoY.

• ▍Revenue kr 558.5M, −2,2% YoY
• ▍Operating income −990,5% YoY
• ▍Net income −1 287,4% YoY
• ▍Free cash flow −716,6% YoY
• ▍Net margin -53.1%

Revenue kr 571.3M, +4,2% YoY; Operating income +35,5% YoY.

• ▍Revenue kr 571.3M, +4,2% YoY
• ▍Operating income +35,5% YoY
• ▍Net income +96,2% YoY
• ▍Free cash flow +99,7% YoY
• ▍Net margin 4.4%

Revenue kr 548.1M, +18,3% YoY; Operating income −19,6% YoY.

• ▍Revenue kr 548.1M, +18,3% YoY
• ▍Operating income −19,6% YoY
• ▍Net income −45,3% YoY
• ▍Free cash flow −30,7% YoY
• ▍Net margin 2.3%